Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Enrico N. De Toni"'
Autor:
Constantin Schmidt, Antonia Zapf, Ann-Kathrin Ozga, Ali Canbay, Ulrike Denzer, Enrico N. De Toni, Ansgar W. Lohse, Kornelius Schulze, Thomas Rösch, Alexander Stein, Henning Wege, Johann von Felden
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Despite the recent advances in cancer treatment, the therapeutic options for patients with biliary tract cancer are still very limited and the prognosis very poor. More than 50% of newly diagnosed patients with biliary tract cance
Externí odkaz:
https://doaj.org/article/227985ca414b4210bc4967508efed47b
Publikováno v:
JHEP Reports, Vol 6, Iss 8, Pp 101146- (2024)
Externí odkaz:
https://doaj.org/article/eda705a60378498ea328a83cd6d0fa87
Autor:
Najib Ben Khaled, Marie Möller, Leonie S. Jochheim, Catherine Leyh, Ursula Ehmer, Katrin Böttcher, Matthias Pinter, Lorenz Balcar, Bernhard Scheiner, Alexander Weich, Hans Benno Leicht, Valentina Zarka, Liangtao Ye, Julia Schneider, Ignazio Piseddu, Osman Öcal, Monika Rau, Friedrich Sinner, Marino Venerito, Simon Johannes Gairing, Friedrich Förster, Julia Mayerle, Enrico N. De Toni, Andreas Geier, Florian P. Reiter
Publikováno v:
JHEP Reports, Vol 6, Iss 6, Pp 101065- (2024)
Background & Aims: Atezolizumab/bevacizumab (atezo/bev) and lenvatinib have demonstrated efficacy as first-line therapies for hepatocellular carcinoma (HCC). However, vascular endothelial growth factor (VEGF) inhibition with these therapies may be as
Externí odkaz:
https://doaj.org/article/8bfa5b4342fd47ce9b2a38f731714629
Autor:
Dominik T. Koch, Haochen Yu, Iris Beirith, Malte Schirren, Moritz Drefs, Yunfei Liu, Mathilda Knoblauch, Dionysios Koliogiannis, Weiwei Sheng, Enrico N. De Toni, Alexandr V. Bazhin, Bernhard W. Renz, Markus O. Guba, Jens Werner, Matthias Ilmer
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-21 (2023)
Abstract Background Despite recent advances in locoregional, systemic, and novel checkpoint inhibitor treatment, hepatocellular carcinoma (HCC) is still associated with poor prognosis. The feasibility of potentially curative liver resection (LR) and
Externí odkaz:
https://doaj.org/article/89af6ca6afb242988daf6262b04f125d
Autor:
Florian P. Reiter, Liangtao Ye, Andrea Ofner, Tobias S. Schiergens, Andreas Ziesch, Lydia Brandl, Najib Ben Khaled, Simon Hohenester, Ralf Wimmer, Renate Artmann, Yulong He, Serene M.L. Lee, Doris Mayr, Changhua Zhang, Alexander L. Gerbes, Julia Mayerle, Gerald Denk, Enrico N. De Toni
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 1, Pp 95-112 (2022)
Background & Aims: Progression of chronic liver disease (CLD) to liver cirrhosis and liver cancer is a major global cause of morbidity and mortality. Treatment options capable of inhibiting progression of liver fibrosis when etiological treatment of
Externí odkaz:
https://doaj.org/article/d5c1e3f3e4744b00bcc68fbf2299c769
Autor:
Osman Öcal, Regina Schinner, Kerstin Schütte, Enrico N. de Toni, Christian Loewe, Otto van Delden, Vincent Vandecaveye, Bernhard Gebauer, Christoph J. Zech, Christian Sengel, Irene Bargellini, Antonio Gasbarrini, Bruno Sangro, Maciej Pech, Peter Malfertheiner, Jens Ricke, Max Seidensticker, for the SORAMIC study group
Publikováno v:
Cancer Imaging, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background The aim of this study was to explore the relationship between follow-up imaging characteristics and overall survival (OS) in advanced hepatocellular carcinoma (HCC) patients under sorafenib treatment. Methods Associations between
Externí odkaz:
https://doaj.org/article/971541f80cc14c379bd9083efd0fc4b4
Autor:
Katherine Baria, Enrico N. De Toni, Binbing Yu, Zhuoxin Jiang, Shaum M. Kabadi, Matteo Malvezzi
Publikováno v:
Gastro Hep Advances, Vol 1, Iss 4, Pp 618-626 (2022)
Background and Aims: Biliary tract cancer (BTC) consists of a group of hepatic and perihepatic tumors that are in close proximity but are anatomically different, including gallbladder cancer (GBC), cholangiocarcinoma (extrahepatic and intrahepatic [I
Externí odkaz:
https://doaj.org/article/78683ed8292d4836aeff6b805d97894e
Autor:
Liangtao Ye, Julia S. Schneider, Najib Ben Khaled, Peter Schirmacher, Carolin Seifert, Lea Frey, Yulong He, Andreas Geier, Enrico N. De Toni, Changhua Zhang, Florian P. Reiter
Publikováno v:
Liver Cancer, Pp 1-1 (2023)
Background Combined hepatocellular-cholangiocarcinoma (cHCC-iCCA) is a rare type of primary liver cancer displaying characteristics of both hepatocytic and cholangiocytic differentiation. Summary Because of its aggressive nature, patients with cHCC-i
Externí odkaz:
https://doaj.org/article/7dcff6221e134cee91cd6d3df1483672
Autor:
Lydia Brandl, David Horst, Thomas G. P. Grünewald, Julia Mayerle, Andrea Sendelhofert, Jens Neumann, Thomas Kirchner, Enrico N. De Toni
Publikováno v:
Cellular Physiology and Biochemistry, Vol 53, Iss 5, Pp 820-831 (2019)
Externí odkaz:
https://doaj.org/article/5812ade5d75f4f53a04f91b2cacc5603
Autor:
Franziska Walter, Frederik Fuchs, Sabine Gerum, Maya C. Rottler, Robert Erdelkamp, Jens Neumann, Lukas Nierer, Markus Guba, Enrico N. De Toni, Max Seidensticker, Jens Ricke, Claus Belka, Stefanie Corradini
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundIn the treatment of patients with HCC awaiting liver transplantation (LT), local ablative treatments (LAT) are available either for downstaging or as bridging treatment. We present our clinical experience with both available radiation-based
Externí odkaz:
https://doaj.org/article/d12bd41aaeb14726b77dad469187c01e